MAP PHARMACEUTICALS, INC. Earnings Per Share (Diluted)
MAP PHARMACEUTICALS, INC. reported Earnings Per Share (Diluted) of -$0.38 per share for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2012-09-30 was -$0.38, a 246.15% decline year-over-year.
- MAP PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2011-09-30 was $0.26.
- MAP PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2011-06-30 was -$0.28.
- MAP PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2010-09-30 was -$0.53.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed |
|---|---|---|---|---|---|
| 2012-09-30 | -$0.38 10-Q · filed 2012-11-06 | -$1.39 10-Q · filed 2012-11-06 | |||
| 2011-09-30 | $0.26 10-Q · filed 2012-11-06 | $0.35 10-Q · filed 2011-11-08 | -$0.10 derived: net income ÷ weighted average shares · filed 2012-11-06 | -$0.63 10-Q · filed 2012-11-06 | $0.64 10-Q · filed 2011-11-08 |
| 2011-06-30 | -$0.28 10-Q · filed 2011-08-08 | $0.28 10-Q · filed 2011-08-08 | |||
| 2010-09-30 | -$0.53 10-Q/A · filed 2012-03-30 | -$1.00 derived: net income ÷ weighted average shares · filed 2012-03-30 | -$1.55 10-Q/A · filed 2012-03-30 | ||
| 2010-06-30 | -$0.47 10-Q · filed 2011-08-08 | -$1.01 10-Q · filed 2011-08-08 |